331 related articles for article (PubMed ID: 28912212)
1. Risk Stratification Using the CHA
Parodi G; Scudiero F; Citro R; Silverio A; Bellandi B; Zito C; Antonini-Canterin F; Rigo F; Zocchi C; Bossone E; Salerno-Uriarte J; Piscione F; Mario CD;
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28912212
[TBL] [Abstract][Full Text] [Related]
2. Relationship between CHA
Scudiero F; Zocchi C; De Vito E; Tarantini G; Marcucci R; Valenti R; Migliorini A; Antoniucci D; Marchionni N; Parodi G
Int J Cardiol; 2018 Jul; 262():9-13. PubMed ID: 29602582
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the CHA
Peng H; Sun Z; Chen H; Zhang Y; Ding X; Zhao XQ; Li H
Am J Cardiol; 2019 Aug; 124(4):476-484. PubMed ID: 31235063
[TBL] [Abstract][Full Text] [Related]
4. Validation of the CHA2DS2-VASc Score in Predicting Coronary Atherosclerotic Burden and In-Hospital Mortality in Patients With Acute Coronary Syndrome.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Jul; 120(1):8-14. PubMed ID: 28479165
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of GRACE risk score in Takotsubo syndrome.
Scudiero F; Arcari L; Cacciotti L; De Vito E; Marcucci R; Passaseo I; Limite LR; Musumeci MB; Autore C; Citro R; Bossone E; Sanna GD; Bacchi B; Volpe M; Di Mario C; Parodi G
Eur Heart J Acute Cardiovasc Care; 2020 Oct; 9(7):721-728. PubMed ID: 31642689
[TBL] [Abstract][Full Text] [Related]
6. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
[TBL] [Abstract][Full Text] [Related]
7. Pre-admission CHA2DS2-VASc score and outcome of patients with acute cerebrovascular events.
Topaz G; Pereg D; Shuvy M; Mausbach S; Kimiagar I; Telman G; Kitay-Cohen Y; Vorobeichik D; Shlomo N; Tanne D
Int J Cardiol; 2017 Oct; 244():277-281. PubMed ID: 28645805
[TBL] [Abstract][Full Text] [Related]
8. CHA
Guerra F; Scappini L; Maolo A; Campo G; Pavasini R; Shkoza M; Capucci A
Eur Heart J Acute Cardiovasc Care; 2018 Apr; 7(3):264-274. PubMed ID: 27708110
[TBL] [Abstract][Full Text] [Related]
9. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
10. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
11. Predictive ability of the CHADS2 and CHA2DS2-VASc scores for stroke after transcatheter aortic balloon-expandable valve implantation: an Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) sub-analysis.
Conrotto F; D'Ascenzo F; D'Onofrio A; Agrifoglio M; Chieffo A; Cioni M; Regesta T; Tarantini G; Gabbieri D; Saia F; Tamburino C; Ribichini F; Cugola D; Aiello M; Sanna F; Iadanza A; Pompei E; Stolcova M; Cappai A; Minati A; Cassese M; Martinelli GL; Agostinelli A; Gerosa G; Gaita F; Rinaldi M; Salizzoni S
Eur J Cardiothorac Surg; 2016 Nov; 50(5):867-873. PubMed ID: 27354254
[TBL] [Abstract][Full Text] [Related]
12. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
Taşolar H; Çetin M; Ballı M; Bayramoğlu A; Otlu YÖ; Türkmen S; Aktürk E
Anatol J Cardiol; 2016 Oct; 16(10):742-748. PubMed ID: 27025198
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
Jover E; Roldán V; Gallego P; Hernández-Romero D; Valdés M; Vicente V; Lip GY; Marín F
Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):627-33. PubMed ID: 22609214
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of CHA
Wang X; Pei C; Bai Y; Dai Q; Deng X; Liu Y; Li Z; You J; Peng J; Lin L; Zou Y
Angiology; 2019 Oct; 70(9):878-886. PubMed ID: 30317861
[TBL] [Abstract][Full Text] [Related]
15. CHA
Rapacciuolo A; Mancusi C; Canciello G; Izzo R; Strisciuglio T; de Luca N; Ammirati G; de Simone G; Trimarco B; Losi MA
Sci Rep; 2019 May; 9(1):7888. PubMed ID: 31133712
[TBL] [Abstract][Full Text] [Related]
16. CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation.
Glotzer TV; Hellkamp AS; Lee KL; Lamas GA
Can J Cardiol; 2015 Aug; 31(8):1004-11. PubMed ID: 26076964
[TBL] [Abstract][Full Text] [Related]
17. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
18. CHA2DS2-VASc Score as an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality after Primary PCI in Patients with Acute ST Segment Elevation Myocardial Infarction.
Ashoori A; Pourhosseini H; Ghodsi S; Salarifar M; Nematipour E; Alidoosti M; Haji-Zeinali AM; Nozari Y; Amirzadegan A; Aghajani H; Jalali A; Hosseini Z; Jenab Y; Geraiely B; Omidi N
Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30717292
[TBL] [Abstract][Full Text] [Related]
19. A Novel Risk Scoring System to Predict Cardiovascular Death in Patients With Acute Myocardial Infarction: CHA
Kundi H; Kiziltunc E; Korkmaz A; Cicek G; Ornek E; Ileri M
Clin Appl Thromb Hemost; 2018 Mar; 24(2):273-278. PubMed ID: 28627231
[TBL] [Abstract][Full Text] [Related]
20. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy.
Paoletti Perini A; Bartolini S; Pieragnoli P; Ricciardi G; Perrotta L; Valleggi A; Vergaro G; Michelotti F; Boggian G; Sassone B; Mascioli G; Emdin M; Padeletti L
Europace; 2014 Jan; 16(1):71-80. PubMed ID: 23828875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
